Fig. 1

Kaplan-Meier survival curves illustrating the cumulative revascularization-free survival in patients prescribed DAPT compared to those receiving AMT throughout the entire follow-up duration. The AMT group (blue) shows a relatively higher revascularization-free survival compared to the DAPT group (purple). “+” indicates censored patients who were lost to follow-up or did not experience revascularization by the end of the study